Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair “tetrafecta” Analysis (ROBUUST Collaborative Group)
Authors:
- 1 June 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 36 (6) , 752-759
Abstract
Purpose: To compare the outcomes of robotic radical nephroureterectomy (RRNU) and laparoscopic radical nephroureterectomy (LRNU) within a large multi-institutional worldwide dataset. Materials and Methods: The ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) includes data from 17 centers worldwide regarding 877 RRNU and LRNU performed between 2015 and 2019. Baseline features, perioperative and oncologic outcomes, were included. A 2:1 nearest-neighbor propensity-score matching with a 0.001 caliper was performed. A univariable and a multivariable logistic regression model were built to evaluate the predictors of a composite “tetrafecta” outcome defined as occurrence of bladder cuff excision+LND+no complications+negative surgical margins. Results: After matching, 185 RRNU and 91 LRNU were assessed. Patients in the RRNU group were more likely to undergo bladder cuff excision (81.9% vs 63.7%; p < 0.001) compared to the LRNU group. A statistically significant difference was found in terms of overall postoperative complications ( p = 0.003) and length of stay ( p < 0.001) in favor of RRNU. Multivariable analysis demonstrated that LRNU was an independent predictor negatively associated with achievement of “tetrafecta” (odds ratio: 0.09; p = 0.003). Conclusions: In general, RRNU and LRNU offer comparable outcomes. While the rate of overall complications is higher for LRNU in this study population, this is mostly related to low-grade complications, and therefore with more limited clinical relevance. RRNU seems to offer shorter hospital stay, but this might also be related to the different geographical location of participating centers. Overall, the implementation of robotics might facilitate achievement of a “tetrafecta” outcome as defined in the present study.Keywords
This publication has 20 references indexed in Scilit:
- Guidelines for Reporting of Statistics for Clinical Research in UrologyJournal of Urology, 2019
- Does Advancing Technology Improve Outcomes? Comparison of the Da Vinci Standard/S/Si to the Xi Robotic Platforms During Robotic NephroureterectomyJournal of Endourology, 2018
- Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologistsUrologic Oncology: Seminars and Original Investigations, 2017
- Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tractCancer, 2017
- External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based studyUrologic Oncology: Seminars and Original Investigations, 2017
- Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population–based analysis (2004–2012)Urologic Oncology: Seminars and Original Investigations, 2016
- Robot-assisted versus laparoscopic nephroureterectomy for uppertract urothelial cancer: A population-based assessment of costs and perioperative outcomesCanadian Urological Association Journal, 2014
- Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaEuropean Urology, 2014
- Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial)European Urology, 2011
- Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: A prospective randomized studyInternational Journal of Urology, 2001